Scarica l'app Stockscreener
147.20
0.35%
0.52
Dopo l'orario di chiusura:
147.31
0.11
+0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$146.68
Aprire:
$146.88
Volume 24 ore:
1.43M
Relative Volume:
0.38
Capitalizzazione di mercato:
$31.11B
Reddito:
$398.11M
Utile/perdita netta:
$-1.03B
Rapporto P/E:
-25.87
EPS:
-5.69
Flusso di cassa netto:
$-868.57M
1 W Prestazione:
+1.31%
1M Prestazione:
+34.37%
6M Prestazione:
+96.55%
1 anno Prestazione:
+104.96%
Intervallo 1D:
$145.25
$149.08
Intervallo di 1 settimana:
$140.33
$149.08
Portata 52W:
$60.40
$149.08
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
147.20 | 31.00B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
Short Interest Drops in Insmed Incorporated After RallyEarnings Risk Report & Breakout Confirmation Alerts - beatles.ru
DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight - GlobeNewswire Inc.
Insmed stock hits 52-week high at 146.91 USD - Investing.com
Should I buy Insmed Incorporated stock now2025 Geopolitical Influence & Daily Momentum Trading Reports - beatles.ru
A | Price Reversal in Insmed Incorporated? Traders Watch CloselyBreakout Watch & Consistent Growth Equity Picks - beatles.ru
Chart based exit strategy for Insmed IncorporatedWeekly Trade Review & Long-Term Safe Investment Plans - Newser
Should you wait for a breakout in Insmed IncorporatedEarnings Trend Report & Real-Time Buy Signal Alerts - Newser
Live market analysis of Insmed IncorporatedRate Hike & Technical Confirmation Trade Alerts - Newser
Will Insmed Incorporated benefit from rate cutsJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
What the charts say about Insmed Incorporated today2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser
Insmed at Wells Fargo Conference: Strategic Growth and Future Plans By Investing.com - Investing.com Canada
Insmed at Wells Fargo Conference: Strategic Growth and Future Plans - Investing.com
Significant Outflows Detected in Biotech ETFs: XBI, ALNY, INSM, HALO - AInvest
Can Insmed Incorporated lead its sector in growthWeekly Stock Report & Weekly Consistent Profit Watchlists - خودرو بانک
Custom watchlist performance reports with Insmed IncorporatedJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
Transcript : Insmed Incorporated Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-05-2025 08 - MarketScreener
Key resistance and support levels for Insmed IncorporatedQuarterly Market Summary & Technical Pattern Recognition Alerts - Newser
Combining price and volume data for Insmed IncorporatedMarket Movement Recap & AI Driven Price Forecasts - Newser
Will earnings trigger a reversal in Insmed IncorporatedJuly 2025 Movers & Weekly High Return Opportunities - Newser
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - MarketScreener
Insmed CMO Flammer sells $26.9m in stock after option exercise - Investing.com Australia
Insmed's Tumultuous Day Insider Sales and 20 Volume Drop Sink Stock to 372nd Market Rank - AInvest
Has Insmed Incorporated found a price floorEarnings Overview Summary & Community Consensus Picks - Newser
Insmed CLO Smith sells $3.49m in shares - Investing.com
Insmed scores pivotal win in bronchiectasis with FDA approval of Brinsupri - Yahoo Finance
Insmed Announces FDA Approval For Drug To Treat Chronic Lung Disease - MSN
Developing predictive dashboards with Insmed Incorporated data2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Is Insmed Incorporated forming a reversal patternTrade Analysis Report & Daily Volume Surge Signals - Newser
Will Insmed Incorporated stock hit new highs in YEARTreasury Yields & Detailed Earnings Play Alerts - خودرو بانک
Analyzing net buyer seller activity in Insmed IncorporatedJuly 2025 Review & Target Return Focused Picks - Newser
Sentiment analysis tools applied to Insmed IncorporatedJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser
Insmed Shares Slide 1.24% Amid 48.65% Volume Drop to 286th Rank as Wells Fargo Raises Target to $171 - AInvest
Trend Review: Will Insmed Incorporated benefit from rate cutsRecession Risk & Smart Money Movement Alerts - خودرو بانک
Mizuho Securities Keeps Their Buy Rating on Insmed (INSM) - The Globe and Mail
Analyzing drawdowns of Insmed Incorporated with statistical tools2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $142 to $171 - 富途牛牛
Signal strength of Insmed Incorporated stock in tech scannersGlobal Markets & Smart Money Movement Tracker - Newser
Is Insmed Incorporated still worth holding after the dip2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Insmed (INSM) Soars 6.76% After FDA Approves Brinsupri for Non-CF Bronchiectasis - AInvest
Will Insmed Incorporated outperform small cap indexesWeekly Trade Review & AI Forecast for Swing Trade Picks - خودرو بانک
Insmed (INSM) Surges 6.76% on Bullish Technical Signals Faces Key Resistance at $140 - AInvest
Insmed Stock Surges 13.23% to $145.30 Amid Strong Bullish Momentum - AInvest
Is Insmed Incorporated stock forming a cup and handleMarket Sentiment Summary & Entry Point Confirmation Alerts - خودرو بانک
Why United Just Catapulted 39%, Pulling Two Rivals With It - Investor's Business Daily
Brinsupri Boost: Is Insmed Stock Undervalued? - StocksToTrade
What high frequency data says about Insmed Incorporated2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Insmed Stock Soars: Buy or Hold Timeout? - timothysykes.com
Insmed Stock Jumps: What’s Driving Change? - StocksToTrade
What analysts say about Insmed Incorporated stockEarnings Risk Report & Growth Focused Stock Pick Reports - khodrobank.com
Buy Rating for Insmed: Promising Market Potential and Strategic Advancements in TPIP Development - TipRanks
Insmed Surges 5.9% on Intraday Rally: What’s Fueling the Momentum? - AInvest
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Insmed Inc Azioni (INSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Smith Michael Alexander | Chief Legal Officer |
Sep 02 '25 |
Sale |
143.89 |
24,272 |
3,492,378 |
54,902 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 02 '25 |
Option Exercise |
23.40 |
186,648 |
4,366,788 |
269,759 |
| Flammer Martina M.D. | Chief Medical Officer |
Sep 02 '25 |
Sale |
144.34 |
186,648 |
26,941,272 |
83,111 |
0.56%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):